Accession Number: | 0000899243-20-018121 |
Date: | 2020-06-30 |
Issuer: | FULCRUM THERAPEUTICS, INC. (FULC) |
Original Submission Date: |
WALLACE OWEN B.
C/O FULCRUM THERAPEUTICS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-06-30 | M | 141 | a | $7.84 | 127,229 | direct | ||
COMMON STOCK | 2020-06-30 | S | 141 | d | $20.00 | 127,088 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 7.84 | 2020-06-30 | deemed execution date | M | 141 (d) | 2029-01-21 | common stock 141 | $7.84 | 84,893 | direct |
ID | footnote |
---|---|
f1 | the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 26, 2019. |
f2 | the shares underlying the option are scheduled to vest in equal quarterly installments from january 1, 2019 through december 31, 2022. |